Skip to main content
Log in

The seroprevalence of both hepatitis B and hepatitis C at the first-step health organizations and the difference between the urban and rural areas

  • original article
  • Published:
Wiener klinische Wochenschrift Aims and scope Submit manuscript



Hepatitis B virus (HBV) and hepatitis C virus (HCV) are very important infectious agents for public health. The aim of this retrospective study was to assess the seroprevalence of hepatitis B surface antigen (HBsAg), hepatitis B surface antibody (anti-HBs) and anti-HCV test results of patients who admitted to first-step health organizations in central and peripheral districts of Konya, the central region of Turkey during the period 2005–2010.


In this study, HBsAg, anti-HBs and anti-HCV screening test results of patients who admitted to first-step health organizations in Konya during the period 2005–2010 were retrospectively investigated from the laboratory records. This study was approved by the Konya Health Directorate. All screening tests were performed on the automatic third-generation enzyme-linked immunosorbent assay (MEIA). This immunoassay method was carried out according to the instructions of the manufacturer. Borderline and positive results were retested.


Konya is the largest city of Turkey in terms of surface area and one of the economically developed cities. For HBsAg, anti-HBs and anti-HCV screening, whole test results of 5 years are given in Table 1 and Figure 1. The differences between the urban and rural for HBsAg (p = 0.062 > 0.05) and anti-HCV(p = 0.874 > 0.05) were not statistically significant. Among the markers only for anti-HBs, the difference between the urban and rural was statistically significant (P = 0.042 < 0.05). Of them, 4.15 % were positive for HBsAg, 36.46 % were positive for anti-HBs and 1.16 % were positive for anti-HCV.


In this study, Konya has been evaluated as two regions: central and peripheral. Our study showed us that distribution of the diseases vary from one region to another. We consider that difference in social diversity is one of the factors. These infections are major health problems. So the results of immunodiagnostic tests for HBsAg, anti-HBs and anti-HCV will be useful for guiding control actions and for new preventive strategies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others


  1. Alencar Ximenes RA, Pereira LMB, Martelli CMT, Merchán-Hamann E, et al. Methodology of a nationwide cross-sectional survey of prevalence and epidemiological patterns of hepatitis A, B and C infection in Brazil. Cad Saúde Pública, Rio de Janeiro. 2010;26(9):1693–704.

  2. Wang YB, Chen EQ, Cui YL, et al. Seroprevalence of hepatitis B virus markers in individuals for physical examination in West China Hospital, China. Eur Rev Med Pharmacol Sci. 2011;15(6):592–6.

    CAS  PubMed  Google Scholar 

  3. Zhang H, Li Q, Sun J, Wang C, Gu Q. Seroprevalence and risk factors for hepatitis B infection in an adult population in Northeast China. Int J Med Sci. 2011;8:321–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Hepatitis B. Accessed Nov 2013.

  5. Acar A, Kemahli S, Altunay H, et al. HBV, HCV and HIV seroprevalence among blood donors in Istanbul, Turkey: how effective are the changes in the national blood transfusion policies?. Braz J Infect Dis. 2010;14(1):41–4.

    Article  PubMed  Google Scholar 

  6. Tonial GC, Passos AM, Livramento L, et al. Hepatitis B marker seroprevalence and vaccination coverage in adolescents in the City of Itajaí, State of Santa Catarina, Southern Brazil, in 2008. Rev Soc Bras Med Trop. 2011:44(4):416–9.

    Article  PubMed  Google Scholar 

  7. Voigt AR, Neto MS, Spada C, Treitinger A. Seroprevalence of hepatitis B and hepatitis C markers among children and adolescents in the south Brazilian region—metropolitan area of Florianópolis, Santa Catarina. Braz J Infect Dis. 2010;14(1):60–5.

    PubMed  Google Scholar 

  8. Hepatitis C. Accessed Nov 2013.

  9. Weinbaum CM, Mast EE, Ward JW. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. Hepatology. 2009;49:35–44.

    Article  Google Scholar 

  10. Liaw YF. Management of patients with chronic hepatitis B. J Gastroenterol Hepatol. 2002;17:406–8.

    Article  PubMed  Google Scholar 

  11. Chang MH. Hepatitis B virus infection. Semin Fetal Neonatal Med. 2007;12:160–7. 2002;3:382–8.

    Article  PubMed  Google Scholar 

  12. Özdemir M, Baykan M. Kan merkezimize başvuran gönüllü donörlerde hepatit B, hepatit C ve HIV seroprevalansı. Selçuk Tıp Derg. 2005;21(1):1–4.

  13. Kaya S, Arıdoğan BC, Adiloğlu AK, Demirci M. Isparta bölgesi kan donörlerinde HBsAg ve anti-HCV seroprevalansı. S.D.Ü. Tıp Fak Derg. 2005;12:36–8.

  14. Sakarya S, Tuncer G, Yaşa H, Çiçek C, Kadıköylü G, Yükselen V. Aydın bölgesindeki kan donörlerinde HBsAg ve anti-HCV seroprevalansı ve yaş ve cinsiyetle ilişkisi. KLİMİK Derg 2001;1:22–4. (8)

  15. Dilek İ, Demir C, Bay A, Akdeniz H, Öner AF. Seropositivity rates of HBsAg, anti-HCV, anti-HIV and VDRL in blood donors in Eastern Turkey. Turk J Hematol. 2007;24:4–7.

    Google Scholar 

  16. Keskinler DÜ. Erzurum Kızılay Kan Merkezi’ne başvuran kan donörlerinin HBV ve HCV yönünden serolojik değerlendirilmesi. İnönü Üniversitesi Tıp Fakültesi Dergisi. 2003;10:195–8.

    Google Scholar 

  17. Otağ F, Köksel T. Mersin Tıp Fakültesi Araştırma ve Uygulama Hastanesi Kan Merkezi donörlerinin infeksiyon etkenleri tarama sonuçlarının değerlendirilmesi. MEÜ Tıp Fak Derg. 2002;3:382–8.

    Google Scholar 

  18. Temiz H, Gül K. Kan vericilerinin HBsAg, anti-HCV, anti-HIV ve VDRLtest sonuçlarının değerlendirilmesi. Turk J Infect. 2008;22(2):79–82.

    Google Scholar 

  19. Demiraslan H, Aksöz S. Adıyaman İli Kan Vericilerindeki HBsAg ve Anti- HCV Sıklığının Değerlendirilmesi. Viral Hepatit Dergisi. 2008;13(1):23–6.

    Google Scholar 

  20. Turan H, Şerefhanoğlu K, Kanat-Unler G, Arslan H. Konya İlinde Kan Donorlerinde HBsAg ve Anti-HCV Seroprevalansı ve Yaş ve Cinsiyetle İlişkisİ. Klimik Dergisi. 2011;24(1):36–9.

    Article  Google Scholar 

  21. Bhattacharya P, Chandra PC, Datta S, et al. Significant increase in HBV, HCV, HIV and syphilis infections among blood donors in West Bengal, Eastern India 2004–2005: exploratory screening reveals high frequency of occult HBV infection. World J Gastroenterol. 2007;13(27):3730–3.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Gheorghe L, Csiki I, Iacob S, Gheorghe C. The prevalence and risk factors of hepatitis B virus infection in an adult population in Romania: a nationwide survey. Eur J Gastroenterol Hepatol. 2012;10. [Epub ahead of print]

  23. Guzelant A, Kurtoğlu MG, Kaya M, Keşli R, Baysal B. Kan vericilerinde ve bir ağız-diş sağlığı merkezi calışanlarında hepatit B, hepatit C ve HIV seroprevalansı ile vericilerde risk faktorlerinin araştırılması. İnfeks Derg. 2008;22(4):189–95.

    Google Scholar 

  24. Majori S, Baldo V, Tommasi I, Malizia M, Floreani A, Monteiro G, et al. Hepatitis A, B, and C infection in a community of sub Saharan Immigrants Living in Verona (Italy). J Travel Med. 2008;15(5):323–7.

    Article  PubMed  Google Scholar 

  25. Vasilopoulou VA, Hadjichristodoulou C. Migration and viral hepatitis. Viral Hepat. 2008;16:18–9.

    Google Scholar 

  26. El Beltagy KE, Al Balawi IA, Almuneef M, Memish ZA. Prevalence of hepatitis B virus markers among blood donors in a tertiary hospital in Tabuk, northwestern Saudi Arabia. Int J Infect Dis. 2008;12(5):495–9.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Fatma Kalem.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kalem, F., Yüksekkaya, Ş. & Başaranoğlu, M. The seroprevalence of both hepatitis B and hepatitis C at the first-step health organizations and the difference between the urban and rural areas. Wien Klin Wochenschr 128, 695–699 (2016).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: